Showing results (671-680 of 3,470) with videos related to
Sort By:
Pageof 347
Clinical Pharmacokinetics|December 21, 2016
CYP2C8 Genotype Significantly Alters Imatinib Metabolism in Chronic Myeloid Leukaemia PatientsDaniel T Barratt, Hannah K Cox, Andrew Menelaou, et al.Clinical Pharmacokinetics|October 13, 2009
Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalenceLaszlo Tothfalusi, Laszlo Endrenyi, Alfredo Garcia ArietaClinical Pharmacokinetics|March 27, 2014
The pharmacokinetics and pharmacodynamics of TOL101, a murine IgM anti-human αβ T cell receptor antibody, in renal transplant patientsDaniel R Getts, William G Kramer, Alexander C Wiseman, et al.Clinical Pharmacokinetics|May 16, 2008
Pharmacokinetic and pharmacodynamic data to be derived from early-phase drug development: designing informative human pharmacology studiesAdam CohenClinical Pharmacokinetics|October 19, 2016
Clinical Pharmacokinetics and Pharmacodynamics of FebuxostatBishoy Kamel, Garry G Graham, Kenneth M Williams, et al.Clinical Pharmacokinetics|February 12, 2014
Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settingsIftekhar MahmoodClinical Pharmacokinetics|November 9, 2018
Interactions Between Antiepileptic and Antibiotic Drugs: A Systematic Review and Meta-Analysis with Dosing ImplicationsCarla Carnovale, Marco Pozzi, Faizan Mazhar, et al.Clinical Pharmacokinetics|February 17, 2017
Clinical Trial Simulations and Pharmacometric Analysis in Pediatrics: Application to Inhaled Loxapine in Children and AdolescentsMin Dong, Tsuyoshi Fukuda, Sally Selim, et al.Clinical Pharmacokinetics|February 27, 2017
Population Pharmacokinetic Modeling of JNJ-53718678, a Novel Fusion Inhibitor for the Treatment of Respiratory Syncytial Virus: Results from a Phase I, Double-Blind, Randomized, Placebo-Controlled First-in-Human Study in Healthy Adult SubjectsDymphy R H Huntjens, Sivi Ouwerkerk-Mahadevan, Anne Brochot, et al.Clinical Pharmacokinetics|March 15, 2017
Time-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed EpilepsyAndreas Lindauer, Christian Laveille, Armel StockisPageof 347